In a major shift, the US Food and Drug Administration (FDA) today announced that it is looking to study the potential impacts of an alternate format for direct-to-consumer (DTC) television advertising, one in which companies would only be required to list the major—not all—risks associated with the use of a drug.
Association says survey points to 14,000 job cuts and 19,000 delayed hirings, but others say 38-firm sample is too small.
Legislators in the US House of Representatives and Senate are considering bills that would exempt several types of software, mobile medical devices and apps from Food and Drug Administration (FDA) oversight.
The Colorado State University Spring Semester session will be starting in May 2014 regarding FDA 21 CFR 820 in the College of Biomedical Engineering. The title of the class is “FDA Quality System Regulation (21 CFR 820) and ISO 13485:2003 for Medical Devices” [EGLL 4094]. Lori Carr helped develop the material that will be presented during this ten (10) week session. Lori has taught this class during the Spring semesters of 2011, 2012, and 2013. She will assist with the 2014 session as her schedule permits. Please check the CSU website for specific information regarding this class or contact Deanna Scott at 970.402.5330 or e-mail her at Deanna.Scott@ColoState.EDU for more information.
Japan’s Ministry of Health, Labour and Welfare (MHLW) has set a late November 2014 date to begin enforcing revised regulations for medical devices and pharmaceutical products.